Skip to main content
. Author manuscript; available in PMC: 2017 Jun 19.
Published in final edited form as: Mol Neurobiol. 2015 Jan 28;53(2):1296–1309. doi: 10.1007/s12035-015-9091-8

Figure 8.

Figure 8

Open-field analyses of Epm2b+/− (control) and Epm2b−/− (KO) mice untreated (w/o TTT) or treated with the described drugs during one month (A, C, E, G) or two months (B, D, F, H). No significant differences between groups (n: 8–12 mice in each group) were observed in all recorded parameters: total distance roamed (A–B), total immobility time (C–D), number of entries in the more central zone (zone 3) (E–F), or the distance roamed in zone 3 (G–H), according to Kruskal-Wallis non-parametric test followed by Conover-Inman post-hoc test.